Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mifepristone and Misoprostol for 2nd Trimester Abortion in Burkina Faso
NCT03269279Phase 3Unknown
- Sponsor
- Gynuity Health Projects
- Start
- May 2017
- Primary completion
- Dec 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of mifepristone and misoprostol in pregnancy termination, sponsored by Gynuity Health Projects. Primary endpoint: Rate of successful abortion at 24 hours. Status: unknown.
02
Drugs
mifepristonemisoprostol
03
Conditions
pregnancy termination
Beyond the preview
Go deeper on NCT03269279.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03269279.